An important and compelling conversation on uniting the biopharma industry to help patients. Thank you Dr. Jeremy M. Levin Ovid Therapeutics, Ryan Richardson BioNTech SE, Grace Colón Inaya Therapeutics, Will Lewis Insmed Incorporated, & Catherine Sohn, Pharm.D. Altimmune, Inc. #longwoodhealthcareleaders
Inaya Therapeutics
生物技术研究
Developing breakthrough therapies for high unmet need cardiopulmonary conditions
关于我们
Inaya Therapeutics is a privately-held biopharmaceutical company focused on developing breakthrough inhaled therapies with the potential to significantly improve current treatment paradigms for rare cardiopulmonary conditions. The team collectively brings decades of experience in successfully developing cardiopulmonary, inhaled and/or other therapies on a variety of advanced platforms, and includes world class expertise in clinical, pre-clinical, commercial, CMC, corporate development, regulatory/quality and intellectual property. The company is developing a pipeline of therapies for PAH as well as other cardiopulmonary indications.
- 网站
-
www.inayatx.com
Inaya Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 类型
- 私人持股
- 创立
- 2023
动态
-
Inaya Therapeutics co-founder and CEO Grace Colón will be speaking on two panels at #BiotechShowcase next week. Join us for an exciting three days of panels and presentations on key hot topics in biotech! #patientsfirst #biotech #innovation #leadership #policy #womenshealth #healthquity
Biotechnology CEO, Board Member and Entrepreneur | Championing Underrepresented Groups In the Boardroom, C-Suite, and Everywhere | Speaker | Connector | Mentor | Women's Health Advocate | LatinX/Latine ????| Mom
I'm excited to be attending and speaking at #BiotechShowcase, January 13–15, 2025, on two topics near and dear to my heart. On Monday, I'll be on at noon on a panel entitled: "The "New” Policy Landscape: Now that the Election is Behind Us, Where Do We Go from Here?" along with Beth Neitzel, Tony Lanzone, Ted W. Love, MD, and Nouhad Husseini, moderated by industry insider Tim Opler of Stifel Institutional. On Wednesday, I'll be on at 3:30 on "Women’s Health: Innovation Impacting the Different Health Needs of Half the Population", along with Jessica J. Federer, Chris Benecchi, Alice Zheng, and Andrea Pfeifer, moderated by BioSpace's Lori Ellis. Great news! This session is free and open to the public, but you'll need to RSVP to reserve your spot. You can find the full program and register here: https://lnkd.in/gw3quTXH
-
-
Inaya Therapeutics co-founder and CEO will be speaking at Longwood Healthcare Leaders San Francisco CEO this Sunday on a panel about #BioPharma action on behalf of patients, the industry and all stakeholders. #patientsfirst #advocacy #innovation #healthequity #industryaction #JPM
Biotechnology CEO, Board Member and Entrepreneur | Championing Underrepresented Groups In the Boardroom, C-Suite, and Everywhere | Speaker | Connector | Mentor | Women's Health Advocate | LatinX/Latine ????| Mom
Join me at Longwood Healthcare Leaders San Francisco CEO (https://lnkd.in/gVW9HEXi) where I'll be speaking on a panel about #BioPharma action on behalf of patients, the industry and all of our stakeholders. I'm honored to speak alongside Teresa Bitetti, Will Lewis, Catherine Sohn, Pharm.D., moderated by fellow activist, BIO Board Exec Committee member, and dear friend - industry rock star Dr. Jeremy M. Levin. Hope to see you all there! #biotech #biopharma #innovation #patientsfirst #healthequity #industryaction #leadership
-
-
This National Health Education Week, let’s empower women to take control of their heart health! ???? Whether it’s learning about risk factors, understanding symptoms, or getting regular screenings, knowledge is key to prevention. At WomenHeart, we believe in educating women about heart disease so they can live longer, healthier lives. Share heart health resources with the women in your life, and help spread the word about the importance of education in the fight against heart disease. #NationalHealthEducationWeek #HeartHealth #Prevention
-
-
-
-
-
+1
-
-
Exciting progress for our "sister company" InCarda Therapeutics! #AtrialFibrillation remains an enormous unmet need, and the potential to intervene early to stop episodes as soon as they start could dramatically change disease progression over time, including reducing stroke risk and risk of more severe heart disease. Women in particular often don't get the care they need when they present with symptoms. Inaya technology was co-invented by a former InCarda team and uses some of the same fundamental groundbreaking formulation technology in other cardiovascular indications. The Inaya team will be cheering them on in their next exciting steps! #patientsfirst #atrialfibrillation #stopAF #hearthealth #womensheart
Things are happening at InCarda!!! Read all about it: https://lnkd.in/gFUX8e2D Analysis of the results of the RESTORE-1 Phase 3 trial following its premature termination demonstrated statistically significant cardioversion of PAF with orally inhaled flecainide, providing compelling?rationale for the continued development of FlecIH-103 in the target population of PAF patients. —?The RESTORE-1 trial was stopped prematurely due to lower-than-expected efficacy and plasma flecainide levels during a blinded review of the data —?There were no safety concerns associated with the administration of FlecIH-103 A novel drug delivery platform has shown the potential to enable efficient and reliable delivery of flecainide to the heart through the lung, appropriate for both hospital and home use Bridging Phase 1 study data to date establishes a path for future registration trials
-
Happy National Women’s Health and Fitness Day! Let’s celebrate by focusing on our health and fitness. Prioritize your heart health and stay active with great tips from our blog! womenheart.org/blog Share your favorite ways to stay fit and healthy ?? #WomensHealth #Fitness #WomenHeart
-
-
@Inaya co-founder Sheila Gujrathi recently spoke at TEDx San Diego. Watch her inspiring speech!
Biotech Executive | Physician Scientist | Healthcare Investor | Drug Developer | TEDx Speaker | Founder, Mirror Movement | Co-Founder, Biotech CEO Sisterhood
What if the key to truly shattering the glass ceiling is finding the right mirrors? I’m thrilled to share my TEDx talk, “Focus on the Mirror, Not the Glass Ceiling,” on exactly that! You’ll learn how to: ??Hold up your own mirror: Understand who you are and how you process the world around you ?? Surround yourself with mirrors—people who reflect your greatness to transform your career, life, and society at large ?? Be a mirror: Inspire others to see and fulfill their potential Please watch, comment, like and share on YouTube! Here it is! https://lnkd.in/gQE_77qW #TEDxSanDiego #TEDx #GlassCeiling #BreakTheGlassCeiling #Networking #Mentor #Mirrors
Shattering the glass ceiling by finding the right mirrors | Sheila Gujrathi, MD | TEDxSanDiegoWomen
https://www.youtube.com/
-
3x zero-to-one Health Tech Innovator & AI Product Expert | Healthcare AI Consultant, Strategist, Researcher & Educator | Keynote Speaker | Author | Mentor | Women's Health Advocate
No words are needed here... The illustration says it all - the iceberg illusion of women's heart health! Who is ready to become aware of their health and take action? At HerHeartCo, we are developing an interventional solution to empower women with knowledge about their bodies, manage several risk factors, reduce perimenopausal symptoms, and therefore, reduce cardiovascular risk. If you are suffering from any of these risk factors, take action NOW to feel better! You do not have to experience a "traditional heart attack symptom" to take action! We hope you reshare this post to create more awareness! #hearthealth #womenshealth #awareness #womenempowerment #femtech #action
-
-
#PAH is a debilitating, progressive disease of very high unmet need, and it disproportionately affects women. Despite tremendous advances over the past decades, more treatments are desperately needed for patients. Inaya is committed to delivering better solutions for PAH patients and many others who suffer from serious cardiopulmonary conditions. #patientsfirst #womenshealth #innovation #healthequity Chart credit: PAH Initiative
-